NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

心血管疾病基因治療的全球市場規模,現狀,預測(2021年∼2027年)

Global Gene Therapy on Cardiovascular Disease Market Size, Status and Forecast 2021-2027

出版商 QYResearch 商品編碼 1025766
出版日期 內容資訊 英文 83 Pages
商品交期: 2-3個工作天內
價格
心血管疾病基因治療的全球市場規模,現狀,預測(2021年∼2027年) Global Gene Therapy on Cardiovascular Disease Market Size, Status and Forecast 2021-2027
出版日期: 2021年08月31日內容資訊: 英文 83 Pages
簡介

全球心血管疾病的基因治療的市場規模在2020年估算為54萬美金。

該市場在2021年∼2027年間,預測將以105.42%的年複合成長率推移,2027年達到9億8,421萬美元。

本報告提供全球心血管疾病的基因治療市場的相關調查,提供市場規模和預測,成長及阻礙因素,趨勢和課題,類型·用途·企業·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

  • 調查範圍
  • 各類型的市場分析
    • 全球心血管疾病的基因治療的市場規模成長率:2016 VS 2021 VS 2027
    • 病毒基因治療
    • 非病毒基因治療
  • 各用途的市場
    • 全球心血管疾病的基因治療市場:2016 VS 2021 VS 2027
    • 心臟病
    • 血管疾病
  • 調查目的
  • 涵括年份

第2章 全球成長趨勢

  • 全球心血管疾病的基因治療市場展望(2016-2027)
  • 業界動態
    • 市場趨勢
    • 市場成長要素
    • 市場課題
    • 市場阻礙因素

第3章 競爭情形:各企業

  • 各收益:全球主要基因治療企業
    • 各收益:全球主要基因治療企業(2019-2020)
    • 各企業:全球基因治療收益市場佔有率(2019-2020)
  • 主要企業的基因治療產品解決方案與服務
  • 心血管疾病基因治療的主要企業總公司
  • 心血管疾病基因治療企業的開發平台(管線)
  • 合併和收購,擴張計劃

第4章 各類型:明細資料

  • 市場規模(2016-2021)
  • 市場規模預測(2022-2027)

第5章 各用途:明細資料

  • 市場規模(2016-2021)
  • 市場規模預測(2022-2027)

第6章 心血管疾病基因治療的主要企業的簡介

  • Renovacor
    • 企業詳細內容
    • 產業概要
    • 心血管疾病基因治療的簡介
    • 最近的開發
  • Gene Biotherapeutics
  • AskBio
  • Novartis
  • Human Stem Cells Institute

第7章 主要基因治療企業的簡介

  • Biogen
    • 企業詳細內容
    • 主要企業分析
    • 基因治療產品與解決方案
    • 基因治療的收益,毛利,市場佔有率(2019-2020)
  • Novartis
  • Gilead Sciences
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Amgen
  • Spark Therapeutics
  • Akcea Therapeutics
  • Bluebird bio
  • Sunway Biotech
  • SIBIONO
  • AnGes
  • Orchard Therapeutics
  • Human Stem Cells Institute

第8章 分析師的見解/結論

第9章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Analysis and Insights: Global Gene Therapy on Cardiovascular Disease Market

The global Gene Therapy on Cardiovascular Disease market size is projected to reach US$ 984.21 million by 2027, from US$ 0.54 million in 2020, at a CAGR of 105.42% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy on Cardiovascular Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy on Cardiovascular Disease market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy on Cardiovascular Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy on Cardiovascular Disease market.

Global Gene Therapy on Cardiovascular Disease Scope and Market Size

Gene Therapy on Cardiovascular Disease market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Gene Therapy on Cardiovascular Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2016-2027.

By Company

  • Renovacor
  • Gene Biotherapeutics
  • AskBio
  • Human Stem Cells Institute
  • Novartis

Segment by Type

  • Viral Gene Therapy
  • Non-Viral Gene Therapy

Segment by Application

  • Heart Disease
  • Vascular Disease

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Therapy on Cardiovascular Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Viral Gene Therapy
    • 1.2.3 Non-Viral Gene Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Gene Therapy on Cardiovascular Disease Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Heart Disease
    • 1.3.3 Vascular Disease
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Gene Therapy on Cardiovascular Disease Market Perspective (2016-2027)
  • 2.2 Gene Therapy on Cardiovascular Disease Industry Dynamic
    • 2.2.1 Gene Therapy on Cardiovascular Disease Market Trends
    • 2.2.2 Gene Therapy on Cardiovascular Disease Market Drivers
    • 2.2.3 Gene Therapy on Cardiovascular Disease Market Challenges
    • 2.2.4 Gene Therapy on Cardiovascular Disease Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Gene Therapy Players by Revenue
    • 3.1.1 Global Top Gene Therapy Players by Revenue (2019-2020)
    • 3.1.2 Global Gene Therapy Revenue Market Share by Players (2019-2020)
  • 3.2 Key Players Gene Therapy Product Solution and Service
  • 3.3 Gene Therapy on Cardiovascular Disease Key Players Head office
  • 3.4 Pipeline of Gene Therapy on Cardiovascular Disease Company
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 GENE THERAPY ON CARDIOVASCULAR DISEASE BREAKDOWN DATA BY TYPE

  • 4.1 Global Gene Therapy on Cardiovascular Disease Historic Market Size by Type (2016-2021)
  • 4.2 Global Gene Therapy on Cardiovascular Disease Forecasted Market Size by Type (2022-2027)

5 GENE THERAPY ON CARDIOVASCULAR DISEASE BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Gene Therapy on Cardiovascular Disease Historic Market Size by Application (2016-2021)
  • 5.2 Global Gene Therapy on Cardiovascular Disease Forecasted Market Size by Application (2022-2027)

6 KEY GENE THERAPY ON CARDIOVASCULAR DISEASE PLAYERS PROFILES

  • 6.1 Renovacor
    • 6.1.1 Renovacor Company Details
    • 6.1.2 Renovacor Business Overview
    • 6.1.3 Renovacor Gene Therapy on Cardiovascular Disease Introduction
    • 6.1.4 Renovacor Recent Development
  • 6.2 Gene Biotherapeutics
    • 6.2.1 Gene Biotherapeutics Company Details
    • 6.2.2 Gene Biotherapeutics Business Overview
    • 6.2.3 Gene Biotherapeutics Gene Therapy on Cardiovascular Disease Introduction
    • 6.2.4 Gene Biotherapeutics Recent Development
  • 6.3 AskBio
    • 6.3.1 AskBio Company Details
    • 6.3.2 AskBio Business Overview
    • 6.3.3 AskBio Gene Therapy on Cardiovascular Disease Introduction
    • 6.3.4 AskBio Recent Development
  • 6.4 Novartis
    • 6.4.1 Novartis Details
    • 6.4.2 Novartis Major Business Analysis
    • 6.4.3 Novartis Gene Therapy on Cardiovascular Disease Product and Solutions
  • 6.5 Human Stem Cells Institute
    • 6.5.1 Human Stem Cells Institute Details
    • 6.5.2 Human Stem Cells Institute Major Business Analysis
    • 6.5.3 Human Stem Cells Institute Gene Therapy on Cardiovascular Disease Product and Solutions

7 KEY GENE THERAPY PLAYERS PROFILES

  • 7.1 Biogen
    • 7.1.1 Biogen Details
    • 7.1.2 Biogen Major Business Analysis
    • 7.1.3 Biogen Gene Therapy Product and Solutions
    • 7.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.2 Novartis
    • 7.2.1 Novartis Details
    • 7.2.2 Novartis Major Business Analysis
    • 7.2.3 Novartis Gene Therapy Product and Solutions
    • 7.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.3 Gilead Sciences
    • 7.3.1 Gilead Sciences Details
    • 7.3.2 Gilead Sciences Major Business Analysis
    • 7.3.3 Gilead Sciences Gene Therapy Product and Solutions
    • 7.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.4 Sarepta Therapeutics
    • 7.4.1 Sarepta Therapeutics Details
    • 7.4.2 Sarepta Therapeutics Major Business Analysis
    • 7.4.3 Sarepta Therapeutics Gene Therapy Product and Solutions
    • 7.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.5 Alnylam Pharmaceuticals
    • 7.5.1 Alnylam Pharmaceuticals Details
    • 7.5.2 Alnylam Pharmaceuticals Major Business Analysis
    • 7.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Solutions
    • 7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.6 Amgen
    • 7.6.1 Amgen Details
    • 7.6.2 Amgen Major Business Analysis
    • 7.6.3 Amgen Gene Therapy Product and Solutions
    • 7.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.7 Spark Therapeutics
    • 7.7.1 Spark Therapeutics Details
    • 7.7.2 Spark Therapeutics Major Business Analysis
    • 7.7.3 Spark Therapeutics Gene Therapy Product and Solutions
    • 7.7.4 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.8 Akcea Therapeutics
    • 7.8.1 Akcea Therapeutics Details
    • 7.8.2 Akcea Therapeutics Major Business Analysis
    • 7.8.3 Akcea Therapeutics Gene Therapy Product and Solutions
    • 7.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.9 Bluebird bio
    • 7.9.1 Bluebird bio Details
    • 7.9.2 Bluebird bio Major Business Analysis
    • 7.9.3 Bluebird bio Gene Therapy Product and Solutions
    • 7.9.4 Bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.10 Sunway Biotech
    • 7.10.1 Sunway Biotech Details
    • 7.10.2 Sunway Biotech Major Business Analysis
    • 7.10.3 Sunway Biotech Gene Therapy Product and Solutions
    • 7.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.11 SIBIONO
    • 7.11.1 SIBIONO Details
    • 7.11.2 SIBIONO Major Business Analysis
    • 7.11.3 SIBIONO Gene Therapy Product and Solutions
    • 7.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.12 AnGes
    • 7.12.1 AnGes Details
    • 7.12.2 AnGes Major Business Analysis
    • 7.12.3 AnGes Gene Therapy Product and Solutions
    • 7.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.13 Orchard Therapeutics
    • 7.13.1 Orchard Therapeutics Details
    • 7.13.2 Orchard Therapeutics Major Business Analysis
    • 7.13.3 Orchard Therapeutics Gene Therapy Product and Solutions
    • 7.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)
  • 7.14 Human Stem Cells Institute
    • 7.14.1 Human Stem Cells Institute Details
    • 7.14.2 Human Stem Cells Institute Major Business Analysis
    • 7.14.3 Human Stem Cells Institute Gene Therapy Product and Solutions
    • 7.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2019-2020)

8 ANALYST'S VIEWPOINTS/CONCLUSIONS

9 APPENDIX

  • 9.1 Research Methodology
    • 9.1.1 Methodology/Research Approach
    • 9.1.2 Data Source
  • 9.2 Disclaimer
  • 9.3 Author Details

List of Tables and Figures

  • Table 1. Global Gene Therapy on Cardiovascular Disease Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
  • Table 2. Key Players of Viral Gene Therapy
  • Table 3. Key Players of Non-Viral Gene Therapy
  • Table 4. Global Gene Therapy on Cardiovascular Disease Market Size Growth by Application (US$ Million): 2016 VS 2020 VS 2027
  • Table 5. Gene Therapy on Cardiovascular Disease Market Trends
  • Table 6. Gene Therapy on Cardiovascular Disease Market Drivers
  • Table 7. Gene Therapy on Cardiovascular Disease Market Challenges
  • Table 8. Gene Therapy on Cardiovascular Disease Market Restraints
  • Table 9. Global Gene Therapy Revenue by Players (2019-2020) & (US$ Million)
  • Table 10. Global Gene Therapy Market Share by Players (2019-2020)
  • Table 11. Key Players Gene Therapy Product Solution and Service
  • Table 12. Key Players Headquarters and Founded Time
  • Table 13. Pipeline of Gene Therapy on Cardiovascular Disease Company
  • Table 14. Mergers & Acquisitions, Expansion Plans
  • Table 15. Global Gene Therapy on Cardiovascular Disease Market Size by Type (2016-2021) & (US$ Million)
  • Table 16. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type (2016-2021)
  • Table 17. Global Gene Therapy on Cardiovascular Disease Forecasted Market Size by Type (2022-2027) & (US$ Million)
  • Table 18. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type (2022-2027)
  • Table 19. Global Gene Therapy on Cardiovascular Disease Market Size by Application (2016-2021) & (US$ Million)
  • Table 20. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Application (2016-2021)
  • Table 21. Global Gene Therapy on Cardiovascular Disease Forecasted Market Size by Application (2022-2027) & (US$ Million)
  • Table 22. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Application (2022-2027)
  • Table 23. Renovacor Company Details
  • Table 24. Renovacor Business Overview
  • Table 25. Renovacor Gene Therapy on Cardiovascular Disease Product
  • Table 26. Renovacor Recent Development
  • Table 27. Gene Biotherapeutics Company Details
  • Table 28. Gene Biotherapeutics Business Overview
  • Table 29. Gene Biotherapeutics Gene Therapy on Cardiovascular Disease Product
  • Table 30. Gene Biotherapeutics Recent Development
  • Table 31. AskBio Company Details
  • Table 32. AskBio Business Overview
  • Table 33. AskBio Gene Therapy on Cardiovascular Disease Product
  • Table 34. AskBio Recent Development
  • Table 35. Novartis Corporate Information
  • Table 36. Novartis Major Business
  • Table 37. Novartis Gene Therapy on Cardiovascular Disease Product and Solutions
  • Table 38. Human Stem Cells Institute Corporate Information
  • Table 39. Human Stem Cells Institute Major Business
  • Table 40. Human Stem Cells Institute Gene Therapy on Cardiovascular Disease Product and Solutions
  • Table 41. Biogen Corporate Information
  • Table 42. Biogen Major Business
  • Table 43. Biogen Gene Therapy Product and Solutions
  • Table 44. Biogen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 45. Novartis Corporate Information
  • Table 46. Novartis Major Business
  • Table 47. Novartis Gene Therapy Product and Solutions
  • Table 48. Novartis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 49. Gilead Sciences Corporate Information
  • Table 50. Gilead Sciences Major Business
  • Table 51. Gilead Sciences Gene Therapy Product and Solutions
  • Table 52. Gilead Sciences Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 53. Sarepta Therapeutics Corporate Information
  • Table 54. Sarepta Therapeutics Major Business
  • Table 55. Sarepta Therapeutics Gene Therapy Product and Solutions
  • Table 56. Sarepta Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 57. Alnylam Pharmaceuticals Corporate Information
  • Table 58. Alnylam Pharmaceuticals Major Business
  • Table 59. Alnylam Pharmaceuticals Gene Therapy Product and Solutions
  • Table 60. Alnylam Pharmaceuticals Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 61. Amgen Corporate Information
  • Table 62. Amgen Major Business
  • Table 63. Amgen Gene Therapy Product and Solutions
  • Table 64. Amgen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 65. Spark Therapeutics Corporate Information
  • Table 66. Spark Therapeutics Major Business
  • Table 67. Spark Therapeutics Gene Therapy Product and Solutions
  • Table 68. Spark Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 69. Akcea Therapeutics Corporate Information
  • Table 70. Akcea Therapeutics Major Business
  • Table 71. Akcea Therapeutics Gene Therapy Product and Solutions
  • Table 72. Akcea Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 73. Bluebird bio Corporate Information
  • Table 74. Bluebird bio Major Business
  • Table 75. Bluebird bio Gene Therapy Product and Solutions
  • Table 76. Bluebird bio Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 77. Sunway Biotech Corporate Information
  • Table 78. Sunway Biotech Major Business
  • Table 79. Sunway Biotech Gene Therapy Product and Solutions
  • Table 80. Sunway Biotech Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 81. SIBIONO Corporate Information
  • Table 82. SIBIONO Major Business
  • Table 83. SIBIONO Gene Therapy Product and Solutions
  • Table 84. SIBIONO Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 85. AnGes Corporate Information
  • Table 86. AnGes Major Business
  • Table 87. AnGes Gene Therapy Product and Solutions
  • Table 88. AnGes Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 89. Orchard Therapeutics Corporate Information
  • Table 90. Orchard Therapeutics Major Business
  • Table 91. Orchard Therapeutics Gene Therapy Product and Solutions
  • Table 92. Orchard Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 93. Human Stem Cells Institute Corporate Information
  • Table 94. Human Stem Cells Institute Major Business
  • Table 95. Human Stem Cells Institute Gene Therapy Product and Solutions
  • Table 96. Human Stem Cells Institute Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2020)
  • Table 97. Research Programs/Design for This Report
  • Table 98. Key Data Information from Secondary Sources
  • Table 99. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Gene Therapy on Cardiovascular Disease Market Share by Type: 2020
  • Figure 2. Global Gene Therapy on Cardiovascular Disease Market Share by Type: 2027
  • Figure 3. Viral Gene Therapy Features
  • Figure 4. Non-Viral Gene Therapy Features
  • Figure 5. Global Gene Therapy on Cardiovascular Disease Market Share by Application: 2027
  • Figure 6. Gene Therapy on Cardiovascular Disease Report Years Considered
  • Figure 7. Global Gene Therapy on Cardiovascular Disease Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 8. Global Gene Therapy on Cardiovascular Disease Market Size, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 9. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type (2016-2021)
  • Figure 10. Global Gene Therapy on Cardiovascular Disease Revenue Market Share by Type (2022-2027)
  • Figure 11. Bottom-up and Top-down Approaches for This Report
  • Figure 12. Data Triangulation
  • Figure 13. Key Executives Interviewed 70